{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:36:57Z","timestamp":1770986217919,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:00:00Z","timestamp":1552608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00417-019-04291-5","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T20:15:08Z","timestamp":1552680908000},"page":"1013-1018","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Idiopathic retinal vasculitis, aneurysms and neuroretinitis (IRVAN): case series of three patients with multimodal imaging"],"prefix":"10.1007","volume":"257","author":[{"given":"Yu Jeat","family":"Chong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abison","family":"Logeswaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambreen","family":"Sarmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika Marie","family":"Damato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,15]]},"reference":[{"issue":"7","key":"4291_CR1","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0161-6420(95)30907-4","volume":"102","author":"TS Chang","year":"1995","unstructured":"Chang TS, Aylward GW, Davis JL et al (1995) Idiopathic retinal vasculitis, aneurysms, and neuro-retinitis. Retinal Vasculitis Study. Ophthalmology 102(7):1089\u20131097","journal-title":"Ophthalmology"},{"issue":"8","key":"4291_CR2","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/j.ophtha.2006.11.014","volume":"114","author":"MA Samuel","year":"2007","unstructured":"Samuel MA, Equi RA, Chang TS et al (2007) Idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN): new observations and a proposed staging system. Ophthalmology 114(8):1526\u20139.e1","journal-title":"Ophthalmology"},{"issue":"3","key":"4291_CR3","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1097\/IAE.0000000000000769","volume":"36","author":"EJ Sigler","year":"2016","unstructured":"Sigler EJ, Grosso A (2016) Idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome. Retina Phila Pa 36(3):e16\u2013e17","journal-title":"Retina Phila Pa"},{"issue":"2","key":"4291_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4103\/2008-322X.163777","volume":"10","author":"T Banaee","year":"2015","unstructured":"Banaee T, Hosseini SM (2015) Optical coherence tomography features in idiopathic retinal vasculitis, aneurysms and neuroretinitis syndrome. J Ophthalmic Vis Res 10(2):193\u2013196","journal-title":"J Ophthalmic Vis Res"},{"issue":"2","key":"4291_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000341821","volume":"3","author":"C Mar\u00edn-Lamb\u00edes","year":"2012","unstructured":"Mar\u00edn-Lamb\u00edes C, Gallego-Pinazo R, Salom D et al (2012) Rapid regression of exudative maculopathy in idiopathic retinitis, vasculitis, aneurysms and neuroretinitis syndrome after intravitreal ranibizumab. Case Rep Ophthalmol 3(2):251\u2013257","journal-title":"Case Rep Ophthalmol"},{"issue":"1","key":"4291_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000375481","volume":"6","author":"AO Saatci","year":"2015","unstructured":"Saatci AO, Ayhan Z, Take_ \u00d6 et al (2015) Single bilateral dexamethasone implant in addition to panretinal photocoagulation and oral azathioprine treatment in IRVAN syndrome. Case Rep Ophthalmol 6(1):56\u201362","journal-title":"Case Rep Ophthalmol"},{"key":"4291_CR7","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.3928\/23258160-20140331-02","volume":"45","author":"M Basha","year":"2014","unstructured":"Basha M, Brown GC, Palombaro G et al (2014) Management of IRVAN syndrome with observation. Ophthalmic Surg Lasers Imaging Retina 45 Online:e18\u2013e22","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"4291_CR8","unstructured":"Ferris F (1996) Early photocoagulation in patients with either type I or type II diabetes. Trans Am Ophthalmol Soc 94:505"},{"key":"4291_CR9","unstructured":"Akesbi J, Brousseaud FX, Adam R et al (2010) J.P. Intravitreal bevacizumab (Avastin\u00ae) in idiopathic retinitis, vasculitis, aneurysms and neuroretinitis. Acta Ophthalmol 88(2):e40\u20131"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04291-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-019-04291-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04291-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T21:53:05Z","timestamp":1663105985000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-019-04291-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,15]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["4291"],"URL":"https:\/\/doi.org\/10.1007\/s00417-019-04291-5","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,15]]},"assertion":[{"value":"1 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Erika Marie Damato has received speaker fees from AbbVie and Novartis in the past 12\u00a0months. All the other authors declare that they have no conflict of interest","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Consent not required due to retrospective, anonymous and observational nature of this series. The study was performed at the Birmingham Midland Eye Centre. This research was presented at the European Association for Vision and Eye Research conference in NICE (2017). There are no proprietary interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}